UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___)*
OCULAR SCIENCES, INC.
-----------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
-----------------------------------------------------------------
(Title of Class of Securities)
675744 10 6
-------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this
statement [ ]. (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 14 pages
<PAGE>
SCHEDULE 13G
CUSIP No. 675744 10 6 Page 2 of 14 Pages
------------- --- ----
---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners, L. P.
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [X]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
2,678,348
SHARES -----------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
- 0 -
OWNED BY -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
2,678,348
REPORTING -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON WITH
- 0 -
---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,678,348
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [X]
Excludes 11,010 shares held of record by Galen Associates
and 5,004 shares subject to options that are exercisable
by William R. Grant within 60 days of December 31, 1997.
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.3%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
---------------------------------------------------------------------
<PAGE>
SCHEDULE 13G
CUSIP No. 675744 10 6 Page 3 of 14 Pages
------------- --- ----
---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Partners International, L. P.
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [X]
(B) [ ]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
275,711
SHARES -----------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
- 0 -
OWNED BY -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
275,711
REPORTING -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON WITH
- 0 -
---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
275,711
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [X]
Excludes 11,010 shares held of record by Galen Associates
and 5,004 shares subject to options that are exercisable
by William R. Grant within 60 days of December 31, 1997.
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.3%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
---------------------------------------------------------------------
<PAGE>
SCHEDULE 13G
CUSIP No. 675744 10 6 Page 4 of 14 Pages
------------- --- ----
---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Galen Associates
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [X]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
11,010
SHARES -----------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
- 0 -
OWNED BY -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
11,010
REPORTING -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
PERSON WITH
- 0 -
---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
11,010
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [X]
Excludes 5,004 shares subject to options that are exercisable
by William R. Grant within 60 days of December 31, 1997.
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
.1%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
---------------------------------------------------------------------
<PAGE>
SCHEDULE 13G
CUSIP No. 675744 10 6 Page 5 of 14 Pages
------------- --- ----
---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William R. Grant
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [X]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
- 0 -
SHARES -----------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
- 0 -
OWNED BY -----------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
5,004 shares subject to options that are
REPORTING exercisable within 60 days of December 31,
1997.
PERSON -----------------------------------------------------
8 SHARED DISPOSITIVE POWER
WITH
- 0 -
---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
5,004 shares subject to options that are exercisable
within 60 days of December 31, 1997
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
.1%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
---------------------------------------------------------------------
<PAGE>
ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE
------------------------------------------------
OFFICES:
-------
(a) Ocular Sciences, Inc.
(b) 475 Eccles Avenue
South San Francisco, CA 94080
ITEM 2. INFORMATION CONCERNING PERSON FILING:
------------------------------------
(a) Galen Partners, L.P.
(b) 610 Fifth Avenue, 5th Floor
Rockefeller Center
New York, NY 10020
(c) Delaware
(d) Common Stock
(e) 675744 10 6
ITEM 3. STATUS OF PERSON FILING:
-----------------------
Not applicable.
ITEM 4. OWNERSHIP:
---------
(a) 2,678,348
(b) 12.3%
(c) (i) Sole power to vote or to direct vote:
2,678,348 shares
(ii) Shared power to vote or to direct vote:
0 shares
(iii) Sole power to dispose or to direct the
disposition: 2,678,348 shares
(iv) Shared power to dispose or to direct the
disposition: 0 shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
--------------------------------------------
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
------------------------------------------------
ANOTHER PERSON:
--------------
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY:
-----------------------------------------------
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP:
------------------------------------------
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
------------------------------
Not applicable.
ITEM 10. CERTIFICATION:
-------------
Not applicable.
Page 6 of 14 pages
<PAGE>
ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE
------------------------------------------------
OFFICES:
-------
(a) Ocular Sciences, Inc.
(b) 475 Eccles Avenue
South San Francisco, CA 94080
ITEM 2. INFORMATION CONCERNING PERSON FILING:
------------------------------------
(a) Galen Partners International, L.P.
(b) 610 Fifth Avenue, 5th Floor
Rockefeller Center
New York, NY 10020
(c) Delaware
(d) Common Stock
(e) 675744 10 6
ITEM 3. STATUS OF PERSON FILING:
-----------------------
Not applicable.
ITEM 4. OWNERSHIP:
---------
(a) 275,711
(b) 1.3%
(c) (i) Sole power to vote or to direct vote:
275,711 shares
(ii) Shared power to vote or to direct vote:
0 shares
(iii) Sole power to dispose or to direct the
disposition: 275,711 shares
(iv) Shared power to dispose or to direct the
disposition: 0 shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
--------------------------------------------
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
------------------------------------------------
ANOTHER PERSON:
--------------
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY:
-----------------------------------------------
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP:
------------------------------------------
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
------------------------------
Not applicable.
ITEM 10. CERTIFICATION:
-------------
Not applicable.
Page 7 of 14 pages
<PAGE>
ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE
------------------------------------------------
OFFICES:
-------
(a) Ocular Sciences, Inc.
(b) 475 Eccles Avenue
South San Francisco, CA 94080
ITEM 2. INFORMATION CONCERNING PERSON FILING:
------------------------------------
(a) Galen Associates
(b) 610 Fifth Avenue, 5th Floor
Rockefeller Center
New York, NY 10020
(c) Delaware
(d) Common Stock
(e) 675744 10 6
ITEM 3. STATUS OF PERSON FILING:
-----------------------
Not applicable.
ITEM 4. OWNERSHIP:
---------
(a) 11,010
(b) .1%
(c) (i) Sole power to vote or to direct vote:
11,010 shares
(ii) Shared power to vote or to direct vote:
0 shares
(iii) Sole power to dispose or to direct the
disposition: 11,010 shares
(iv) Shared power to dispose or to direct the
disposition: 0 shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
--------------------------------------------
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
------------------------------------------------
ANOTHER PERSON:
--------------
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY:
-----------------------------------------------
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP:
------------------------------------------
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
------------------------------
Not applicable.
ITEM 10. CERTIFICATION:
-------------
Not applicable.
Page 8 of 14 pages
<PAGE>
ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE
------------------------------------------------
OFFICES:
-------
(a) Ocular Sciences, Inc.
(b) 475 Eccles Avenue
South San Francisco, CA 94080
ITEM 2. INFORMATION CONCERNING PERSON FILING:
------------------------------------
(a) William R. Grant
(b) 610 Fifth Avenue, 5th Floor
Rockefeller Center
New York, NY 10020
(c) U.S.A.
(d) Common Stock
(e) 675744 10 6
ITEM 3. STATUS OF PERSON FILING:
-----------------------
Not applicable.
ITEM 4. OWNERSHIP:
---------
(a) 0
(b) .1%
(c) (i) Sole power to vote or to direct vote: 0
shares
(ii) Shared power to vote or to direct vote:
0 shares
(iii) Sole power to dispose or to direct the
disposition: 5,004 shares subject to
exercisable options
(iv) Shared power to dispose or to direct the
disposition: 0 shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
--------------------------------------------
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
------------------------------------------------
ANOTHER PERSON:
--------------
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY:
-----------------------------------------------
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF GROUP:
------------------------------------------
Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
------------------------------
Not applicable.
ITEM 10. CERTIFICATION:
-------------
Not applicable.
Page 9 of 14 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
2/12/98
-----------------------------------
Date
GALEN PARTNERS, L.P.
By: BGW Partners, L.P.
General Partner
By: /s/ Bruce F. Wesson
-------------------------------
Name: Bruce F. Wesson
Title: General Partner
GALEN PARTNERS INTERNATIONAL, L.P.
By: BGW PARTNERS, L.P.
General Partner
By: /s/ Bruce F. Wesson
--------------------------------
Name: Bruce F. Wesson
Title: General Partner
Page 10 of 14 pages
<PAGE>
GALEN ASSOCIATES
By: WESSON ENTERPRISES, INC.
General Partner
By: /s/ Bruce F. Wesson
--------------------------------
Name: Bruce F. Wesson
Title: President
/s/ William R. Grant
-----------------------------------
William R. Grant
Page 11 of 14 pages
<PAGE>
EXHIBIT INDEX
Sequentially
Exhibit Document Description Numbered Page
------- -------------------- --------------
A Agreement of Joint Filing 13
Page 12 of 14 pages
EXHIBIT A
Agreement of Joint Filing
Each of the undersigned hereby agrees that they are filing
jointly pursuant to Rule 13d-1(f)(1) of the Securities Exchange
Act of 1934, as amended, the Statement dated February 12, 1998,
containing the information required by Schedule 13G, for the
shares of Common Stock of Ocular Sciences, Inc. which are held of
record by Galen Partners, L.P., Galen Partners International,
L.P. and Galen Associates and beneficially owned by the
undersigned.
Each of the undersigned hereby expressly disclaims beneficial
ownership of any of such shares as to which he or it does not
have an actual pecuniary interest.
DATED: February 12, 1998
GALEN PARTNERS, L.P.
By: BGW PARTNERS, L.P.
General Partner
By: /s/ Bruce F. Wesson
---------------------------
Name: Bruce F. Wesson
Title: General Partner
GALEN PARTNERS INTERNATIONAL, L.P.
By: BGW PARTNERS, L.P.
General Partner
By: /s/ Bruce F. Wesson
--------------------------------
Name: Bruce F. Wesson
Title: General Partner
Page 13 of 14 pages
<PAGE>
GALEN ASSOCIATES
By: WESSON ENTERPRISES, INC.
General Partner
By: /s/ Bruce F. Wesson
--------------------------------
Name: Bruce F. Wesson
Title: President
/s/ William R. Grant
-----------------------------------
William R. Grant
Page 14 of 14 pages
